Damora Therapeutics DMRA
$23.22 −$1.08 (-4.44%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $23.22 0.00%
Open$23.81
Prev close$24.30
Day range$23.13 – $24.51
Volume643.4K
Market cap$1.44B
P/E (TTM)13.6
Dividend yield–
Analyst view
ConsensusBuy
Analysts6
Average target$46.67+101.0% vs. price
- Buy 100%
Low $40.00Now $23.22Avg $46.67High $59.00
Recent rating changes
The last 20 actions on file set price targets from $40.00 to $60.00, averaging $45.53.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | Wedbush | BUY | $40.00 |
| 5 Nov 2026 | Guggenheim | BUY | $59.00 |
| 5 Nov 2026 | Leerink Partners | BUY | $51.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $45.00 |
| 4 Nov 2026 | RBC Capital | BUY | $40.00 |
| 29 Sep 2026 | Wedbush | BUY | $40.00 |
| 24 Sep 2026 | Guggenheim | BUY | $60.00 |
| 18 Sep 2026 | LifeSci Capital | BUY | $45.00 |
| 11 Aug 2026 | LifeSci Capital | BUY | $45.00 |
| 11 Aug 2026 | Wedbush | BUY | $40.00 |
| 11 Aug 2026 | Jefferies | BUY | $50.00 |
| 11 Aug 2026 | H.C. Wainwright | BUY | $45.00 |
| 10 Aug 2026 | TD Cowen | BUY | – |
| 10 Aug 2026 | RBC Capital | BUY | $40.00 |
| 6 Aug 2026 | LifeSci Capital | BUY | $45.00 |
| 6 Aug 2026 | Wedbush | BUY | $40.00 |
| 5 Aug 2026 | H.C. Wainwright | BUY | $45.00 |
| 30 Jul 2026 | Wedbush | BUY | $40.00 |
| 26 Jul 2026 | Jefferies | BUY | $50.00 |
| 21 Jul 2026 | H.C. Wainwright | BUY | $45.00 |
No comments yet — be the first to weigh in on DMRA.
Sign in to join the discussion.